Amy began her PhD studies at the Babraham Institute in October 2022. She is interested in the epigenetic and gene regulatory mechanisms governing human embryo development, and in particular, the mechanisms controlling epiblast progression during early post-implantation stages. Amy鈥檚 PhD is jointly funded by the Harding Distinguished Postgraduate Scholars Programme and the School of Biological Sciences Doctoral Training Partnership.
Amy obtained her BA in Natural Sciences from the University of Cambridge in 2020. Specialising in reproductive and developmental biology, she completed her dissertation project in Dr. Erica Watson鈥檚 lab. Here, Amy investigated the effect of abnormal folate metabolism on mouse embryo implantation and uterine function.
Before starting her PhD, Amy joined the Rugg-Gunn lab in 2021 as a 51在线 Assistant to explore the potential clinical applications of in vitro derived human amnion-like epithelial cells.